# pathway_0081

[All questions and paired results](../README.md) · [Method](../METHOD.md) · [Source credits](../THIRD_PARTY_NOTICES.md)

**Task:** `pathway`  
**Author expected answer:** **A** — Antifungal biosynthesis. .

| Reviewer | Expected-answer support | Reasoning / lookup | Validity |
|---|---|---|---|
| GPT-6 Luna | supported | lookup-dependent | valid_review |
| Qwen3.8-Flash-Next-NVFP4 | supported | lookup-dependent | valid_review |

**Paired comparison:** key agree; reasoning agree. Agreement is not proof of correctness. These are separate AI judgments, with no forced consensus or changed key.

## Complete original question

```text
[Protein Sequence]
MQAIISTAPGQAALVHDRPLPTIRDGYLLVKTKAVALNPTDWKHIEVTQKPGILFGCDYAGIVEQVGPGVQSGFQPGDRVAGFVHGGNSKEPQDGAFAEYIVAKADLQIHIPEHMSFEEAATLGVGITAVGQGLYQTLSLPFPSPSSIHEDGAEKPANPATQPILIYGASTASGVLGIQFAKLSGFAPLAVCSPDHFDLAERLGAVAVFDYADGEDAVEEIQDYVRGMGQPLLKAWDTISIPSSARFCGDALSSGNGPQYASLLSMTCPRPDVTSTTTMAYTVFGEDWGMGTAHFPASGVDAELGRRWWALVQQLLNEGRIQTHRIIAGEGGLDGVLGGLQQLRDSQVRGGKLVFRV

[Multiple Choices]
A. Antifungal biosynthesis. .
B. 5-methoxycarbonylmethyl-2-thiouridine-tRNA biosynthesis. .
C. L-valine from pyruvate: step 3/4. .
D. One-carbon metabolism
```

<details>
<summary>Original system instructions, verbatim</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Protein Pathway Prediction, which is to predict the primary metabolic or signaling pathway in which a given protein functions. Biological pathways are series of chemical reactions occurring within a cell that are essential for life. Based on the protein's amino acid sequence, you should identify the most relevant pathway from the given options.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## GPT-6 Luna

**Saved status:** `valid_review`.

### Expected-answer support: supported

> A sequence-matched UniProt record annotates the protein's pathway as antifungal biosynthesis, with ECO:0000269 evidence linked to a publication. The archived record also carries this annotation. This supports the key, though the supplied evidence does not independently validate the underlying experiment.

Citations as saved: [C5](#evidence-c5), [H3](#evidence-h3), [H2](#evidence-h2).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The sequence is compatible with an enzyme, but its amino-acid sequence alone does not establish the specific biosynthetic cluster or pathway in which it functions.


**Missing item-specific fact**

> The protein-specific annotation or experimental finding identifying this sequence as ResD, a restricticin-biosynthesis cluster protein associated with antifungal biosynthesis.


**Reason**

> Selecting A depends on a protein-specific pathway assignment absent from the input. Recognizing or retrieving the exact sequence's database annotation is lookup, not a biological argument supplied by the question.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The reviewer evidence supports A; no other choice is supported as the protein's primary pathway. The input itself does not provide enough context to distinguish the pathway without protein-specific information.


### Important caveats

- The benchmark sequence exactly matches the historical and current UniProt sequence, but the author's source snapshot is unknown.
- The pathway annotation is linked to a publication and marked with experimental evidence; the cited study was not independently assessed here.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence is compatible with an enzyme, but its amino-acid sequence alone does not establish the specific biosynthetic cluster or pathway in which it functions.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The protein-specific annotation or experimental finding identifying this sequence as ResD, a restricticin-biosynthesis cluster protein associated with antifungal biosynthesis.",
    "reason": "Selecting A depends on a protein-specific pathway assignment absent from the input. Recognizing or retrieving the exact sequence's database annotation is lookup, not a biological argument supplied by the question."
  },
  "case_id": "pathway_0081",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "H3",
      "H2"
    ],
    "judgment": "supported",
    "reason": "A sequence-matched UniProt record annotates the protein's pathway as antifungal biosynthesis, with ECO:0000269 evidence linked to a publication. The archived record also carries this annotation. This supports the key, though the supplied evidence does not independently validate the underlying experiment."
  },
  "important_caveats": [
    "The benchmark sequence exactly matches the historical and current UniProt sequence, but the author's source snapshot is unknown.",
    "The pathway annotation is linked to a publication and marked with experimental evidence; the cited study was not independently assessed here."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The reviewer evidence supports A; no other choice is supported as the protein's primary pathway. The input itself does not provide enough context to distinguish the pathway without protein-specific information."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "pathway_0081",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "A sequence-matched UniProt record annotates the protein's pathway as antifungal biosynthesis, with ECO:0000269 evidence linked to a publication. The archived record also carries this annotation. This supports the key, though the supplied evidence does not independently validate the underlying experiment.",
    "evidence_ids": ["C5", "H3", "H2"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The sequence is compatible with an enzyme, but its amino-acid sequence alone does not establish the specific biosynthetic cluster or pathway in which it functions.",
    "missing_item_specific_fact": "The protein-specific annotation or experimental finding identifying this sequence as ResD, a restricticin-biosynthesis cluster protein associated with antifungal biosynthesis.",
    "reason": "Selecting A depends on a protein-specific pathway assignment absent from the input. Recognizing or retrieving the exact sequence's database annotation is lookup, not a biological argument supplied by the question."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The reviewer evidence supports A; no other choice is supported as the protein's primary pathway. The input itself does not provide enough context to distinguish the pathway without protein-specific information."
  },
  "important_caveats": [
    "The benchmark sequence exactly matches the historical and current UniProt sequence, but the author's source snapshot is unknown.",
    "The pathway annotation is linked to a publication and marked with experimental evidence; the cited study was not independently assessed here."
  ]
}
```

</details>

## Qwen3.8-Flash-Next-NVFP4

**Saved status:** `valid_review`.

### Expected-answer support: supported

> UniProt entry P0DXV9 (RESD_ASPSL) carries a PATHWAY annotation of 'Antifungal biosynthesis' with evidence code ECO:0000269 (experimental evidence) from PubMed:39105744 (2024 paper characterizing the restricticin biosynthesis cluster in Aspergillus sclerotiorum). The protein is annotated as 'Trans-enoyl reductase resD' / 'Restricticin biosynthesis cluster protein D.' The benchmark sequence matches the canonical entry (357 AA, SHA256 confirmed). The pathway annotation is experimentally supported.

Citations as saved: [C5](#evidence-c5), [H3](#evidence-h3), [C4](#evidence-c4), [C6](#evidence-c6).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The sequence contains trans-enoyl reductase motifs (e.g., GASTASG NAD(P)-binding motif, GADGEDA reductase signature). A model could argue by elimination that trans-enoyl reductases are not found in tRNA thiolation (B), L-valine biosynthesis (C), or one-carbon metabolism (D), making A the only remaining option. However, positively identifying 'Antifungal biosynthesis' as THE pathway (rather than fatty acid biosynthesis, general polyketide biosynthesis, or other secondary metabolite pathways) requires knowing this specific protein belongs to the restricticin cluster in A. sclerotiorum.


**Missing item-specific fact**

> The specific experimental characterization (PubMed:39105744) that placed resD within the restricticin biosynthesis cluster and assigned the pathway label 'Antifungal biosynthesis.' Without this, a trans-enoyl reductase in a fungal genome could be annotated to multiple secondary metabolite pathways or fatty acid biosynthesis.


**Reason**

> While elimination of clearly incompatible distractors (B, C, D) is partially possible from general knowledge of enzyme families, the positive identification of 'Antifungal biosynthesis' as the pathway label for this specific trans-enoyl reductase depends on the item-specific experimental annotation from the 2024 restricticin cluster study. The sequence alone identifies a reductase but does not uniquely specify 'antifungal' biosynthesis over other reductase-containing pathways.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The three distractors (tRNA thiolation, L-valine biosynthesis step 3/4, one-carbon metabolism) are clearly incompatible with a trans-enoyl reductase domain architecture. No other option is defensible for this protein type.


### Important caveats

- The pathway annotation 'Antifungal biosynthesis' is a broad UniProt-level label; the specific compound is restricticin, identified experimentally in 2024.
- The entry was first public in February 2025, so this is a relatively recent annotation; the author's source snapshot is unknown but the sequence and annotation are consistent across entry versions 4 and 6.
- The evidence code ECO:0000269 confirms experimental (not purely computational) support for the pathway assignment.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence contains trans-enoyl reductase motifs (e.g., GASTASG NAD(P)-binding motif, GADGEDA reductase signature). A model could argue by elimination that trans-enoyl reductases are not found in tRNA thiolation (B), L-valine biosynthesis (C), or one-carbon metabolism (D), making A the only remaining option. However, positively identifying 'Antifungal biosynthesis' as THE pathway (rather than fatty acid biosynthesis, general polyketide biosynthesis, or other secondary metabolite pathways) requires knowing this specific protein belongs to the restricticin cluster in A. sclerotiorum.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The specific experimental characterization (PubMed:39105744) that placed resD within the restricticin biosynthesis cluster and assigned the pathway label 'Antifungal biosynthesis.' Without this, a trans-enoyl reductase in a fungal genome could be annotated to multiple secondary metabolite pathways or fatty acid biosynthesis.",
    "reason": "While elimination of clearly incompatible distractors (B, C, D) is partially possible from general knowledge of enzyme families, the positive identification of 'Antifungal biosynthesis' as the pathway label for this specific trans-enoyl reductase depends on the item-specific experimental annotation from the 2024 restricticin cluster study. The sequence alone identifies a reductase but does not uniquely specify 'antifungal' biosynthesis over other reductase-containing pathways."
  },
  "case_id": "pathway_0081",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "H3",
      "C4",
      "C6"
    ],
    "judgment": "supported",
    "reason": "UniProt entry P0DXV9 (RESD_ASPSL) carries a PATHWAY annotation of 'Antifungal biosynthesis' with evidence code ECO:0000269 (experimental evidence) from PubMed:39105744 (2024 paper characterizing the restricticin biosynthesis cluster in Aspergillus sclerotiorum). The protein is annotated as 'Trans-enoyl reductase resD' / 'Restricticin biosynthesis cluster protein D.' The benchmark sequence matches the canonical entry (357 AA, SHA256 confirmed). The pathway annotation is experimentally supported."
  },
  "important_caveats": [
    "The pathway annotation 'Antifungal biosynthesis' is a broad UniProt-level label; the specific compound is restricticin, identified experimentally in 2024.",
    "The entry was first public in February 2025, so this is a relatively recent annotation; the author's source snapshot is unknown but the sequence and annotation are consistent across entry versions 4 and 6.",
    "The evidence code ECO:0000269 confirms experimental (not purely computational) support for the pathway assignment."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The three distractors (tRNA thiolation, L-valine biosynthesis step 3/4, one-carbon metabolism) are clearly incompatible with a trans-enoyl reductase domain architecture. No other option is defensible for this protein type."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "pathway_0081",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "UniProt entry P0DXV9 (RESD_ASPSL) carries a PATHWAY annotation of 'Antifungal biosynthesis' with evidence code ECO:0000269 (experimental evidence) from PubMed:39105744 (2024 paper characterizing the restricticin biosynthesis cluster in Aspergillus sclerotiorum). The protein is annotated as 'Trans-enoyl reductase resD' / 'Restricticin biosynthesis cluster protein D.' The benchmark sequence matches the canonical entry (357 AA, SHA256 confirmed). The pathway annotation is experimentally supported.",
    "evidence_ids": ["C5", "H3", "C4", "C6"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The sequence contains trans-enoyl reductase motifs (e.g., GASTASG NAD(P)-binding motif, GADGEDA reductase signature). A model could argue by elimination that trans-enoyl reductases are not found in tRNA thiolation (B), L-valine biosynthesis (C), or one-carbon metabolism (D), making A the only remaining option. However, positively identifying 'Antifungal biosynthesis' as THE pathway (rather than fatty acid biosynthesis, general polyketide biosynthesis, or other secondary metabolite pathways) requires knowing this specific protein belongs to the restricticin cluster in A. sclerotiorum.",
    "missing_item_specific_fact": "The specific experimental characterization (PubMed:39105744) that placed resD within the restricticin biosynthesis cluster and assigned the pathway label 'Antifungal biosynthesis.' Without this, a trans-enoyl reductase in a fungal genome could be annotated to multiple secondary metabolite pathways or fatty acid biosynthesis.",
    "reason": "While elimination of clearly incompatible distractors (B, C, D) is partially possible from general knowledge of enzyme families, the positive identification of 'Antifungal biosynthesis' as the pathway label for this specific trans-enoyl reductase depends on the item-specific experimental annotation from the 2024 restricticin cluster study. The sequence alone identifies a reductase but does not uniquely specify 'antifungal' biosynthesis over other reductase-containing pathways."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The three distractors (tRNA thiolation, L-valine biosynthesis step 3/4, one-carbon metabolism) are clearly incompatible with a trans-enoyl reductase domain architecture. No other option is defensible for this protein type."
  },
  "important_caveats": [
    "The pathway annotation 'Antifungal biosynthesis' is a broad UniProt-level label; the specific compound is restricticin, identified experimentally in 2024.",
    "The entry was first public in February 2025, so this is a relatively recent annotation; the author's source snapshot is unknown but the sequence and annotation are consistent across entry versions 4 and 6.",
    "The evidence code ECO:0000269 confirms experimental (not purely computational) support for the pathway assignment."
  ]
}
```

</details>

## Existing project source checks of Luna’s review

The notes below were prepared for specific claims in the Luna review. They are not independent validation of Qwen’s claims, expert adjudication, or replacement verdicts.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Reviewer-only source evidence

**Both reviewers received this source evidence separately from the original question. It was not available to the original evaluated model.** Source support and reasoning from the original sequence/choices are distinct assessments.

**Accession:** `P0DXV9` (recovered from dataset image-path metadata, not original question text).  
**Sequence applicability:** historical matched; current matched.  
**Historical cutoff:** 2026-05-07; archived entry version 4. Exact author snapshot unknown.

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXV9.json)  
**Locator:** `/proteinDescription`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:29:49.517632+00:00.  

```json
{"alternativeNames":[{"fullName":{"evidences":[{"evidenceCode":"ECO:0000303","id":"39105744","source":"PubMed"}],"value":"Restricticin biosynthesis cluster protein D"}}],"recommendedName":{"ecNumbers":[{"evidences":[{"evidenceCode":"ECO:0000305","id":"39105744","source":"PubMed"}],"value":"1.-.-.-"}],"fullName":{"evidences":[{"evidenceCode":"ECO:0000303","id":"39105744","source":"PubMed"}],"value":"Trans-enoyl reductase resD"}}}
```

Source SHA-256: `0ea3f01218a5d44f3983e214db9b5571f37b981454f4a8fcafcef626a639e914`.

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXV9.json)  
**Locator:** `/comments/1`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:29:49.517632+00:00.  

```json
{"commentType":"PATHWAY","texts":[{"evidences":[{"evidenceCode":"ECO:0000269","id":"39105744","source":"PubMed"}],"value":"Antifungal biosynthesis"}]}
```

Source SHA-256: `0ea3f01218a5d44f3983e214db9b5571f37b981454f4a8fcafcef626a639e914`.

### Evidence C6

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXV9.json)  
**Locator:** `/references/0`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:29:49.517632+00:00.  

```json
{"citation":{"authors":["Lu Y.","Li Y.","Dou M.","Liu D.","Lin W.","Fan A."],"citationCrossReferences":[{"database":"PubMed","id":"39105744"},{"database":"DOI","id":"10.1021/acs.jafc.4c04244"}],"citationType":"journal article","firstPage":"18520","id":"39105744","journal":"J. Agric. Food Chem.","lastPage":"18527","publicationDate":"2024","title":"Discovery of a hybrid molecule with phytotoxic activity by genome mining, heterologous expression, and OSMAC strategy.","volume":"72"},"referenceNumber":1,"referencePositions":["NUCLEOTIDE SEQUENCE [GENOMIC DNA]","FUNCTION","PATHWAY"]}
```

Source SHA-256: `0ea3f01218a5d44f3983e214db9b5571f37b981454f4a8fcafcef626a639e914`.

### Evidence H2

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/P0DXV9?format=txt&versions=4)  
**Locator:** `lines 15-21`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 4 / 1.  
**Retrieved:** 2026-11-02T04:29:51.221408+00:00.  

```text
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, AND PATHWAY.
RX   PubMed=39105744; DOI=10.1021/acs.jafc.4c04244;
RA   Lu Y., Li Y., Dou M., Liu D., Lin W., Fan A.;
RT   "Discovery of a hybrid molecule with phytotoxic activity by genome mining,
RT   heterologous expression, and OSMAC strategy.";
RL   J. Agric. Food Chem. 72:18520-18527(2024).
```

Source SHA-256: `50948681abaa65d91ada1f1b7abe16915d33f113843973d2c3d87f65be73d5b0`.

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/P0DXV9?format=txt&versions=4)  
**Locator:** `lines 37-37`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 4 / 1.  
**Retrieved:** 2026-11-02T04:29:51.221408+00:00.  

```text
CC   -!- PATHWAY: Antifungal biosynthesis. {ECO:0000269|PubMed:39105744}.
```

Source SHA-256: `50948681abaa65d91ada1f1b7abe16915d33f113843973d2c3d87f65be73d5b0`.

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/pathway.json), zero-based source row 81. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). UniProt and Gene Ontology credits are retained in [source notices](../THIRD_PARTY_NOTICES.md).
